BIOCRYST PHARMACEUTICA
7.5000
27-11月-24 16:45:00
15 分の遅延
株式
+0.0100
+0.13%
本日の幅
7.4250 - 7.6300
ISIN
N/A
ソース
NASDAQ
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 2 2023 07:00:30 提供 Nasdaq GlobeNewswire
-
03 2 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
26 1 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
23 1 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
09 1 2023 07:05:55 提供 Nasdaq GlobeNewswire
-
09 1 2023 07:00:40 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 1 2023 07:00:28 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference
04 1 2023 07:00:46 提供 Nasdaq GlobeNewswire
-
15 12 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 12 2022 16:01:09 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at JMP Securities Hematology & Oncology Summit
05 12 2022 07:00:26 提供 Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Israeli Ministry of Health
28 11 2022 07:00:43 提供 Nasdaq GlobeNewswire
-
10 11 2022 08:00:21 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
09 11 2022 07:00:33 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 11 2022 07:00:46 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Third Quarter 2022 Financial Results and Upcoming Key Milestones
01 11 2022 07:00:35 提供 Nasdaq GlobeNewswire
-
24 10 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst to Report Third Quarter 2022 Financial Results on November 1
18 10 2022 07:00:39 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 10 2022 07:00:45 提供 Nasdaq GlobeNewswire
-
14 9 2022 16:01:10 提供 Nasdaq GlobeNewswire